Delivery Order SPE2DB20D9103-SPE2DB23FE7C6

Award Date 4/13/23
Potential Completion Date 4/14/23
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,120.20 contract is for the delivery of Primaquine 26.3 mg tablets to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at up to $499,999,999, which allows the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $6,873.72, is for the delivery of 14-count packs of 26.3 mg Primaquine tablets. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $12,697.92 firm fixed price delivery order is for the supply of Primaquine 26.3 mg tablets. It is not associated with a set-aside program. DMS Pharmaceutical Group Inc. holds a single-award indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $93,550.00 contract is for the delivery of 4554877999 - Primaquine 26.3 mg Tablets (28s) to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $3,187.17 contract is for the supply of Primaquine 26.3 mg tablets. DMS Pharmaceutical Group holds a single-award indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $37,340.00 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Primaquine 26.3 mg tablets to support the medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and DLA, valued at up to $499,999,999, which allows DLA to...
This is a $10,020 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the supply of Primaquine 26.3 mg tablets and is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical...
This federal contract award, valued at $16,973.88, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order for 4,566,582,812 Primaquine 26.3 mg tablets, with a completion date of December 6, 2024. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,417.96 contract is for the delivery of Primaquine Phosphate, a specialized pharmaceutical product. The award is not associated with any set-aside designation. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) under the SPE2DB prime vendor program. The $22,404.00 firm fixed-price delivery order is for the supply of Primaquine 26.3 mg tablets, with a period of performance through August 6, 2024. DMS Pharmaceutical Group is a key supplier of a wide range of pharmaceutical products and medical supplies to the Department of Defense (DoD) and...
  • SPE2DB20D9103
    Indefinite Delivery Contract
  • SPE2DB20D9103-SPE2DB23FE7C6
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,322.70, is for the delivery of Primaquine 26.3 mg tablets.

DMS Pharmaceutical Group is an established federal contractor and has held a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC allows the DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide.

The contract does not have a set-aside designation, which enables DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal awards across multiple product categories and medical domains. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group has consistently demonstrated its capability to provide a diverse array of pharmaceutical products to the DLA, including specialized medications such as Xolair, Trikafta, Keytruda, Botox, and Nucala.

Generated 2/27/25, 1:27 PM